دورية أكاديمية
Role of creatine shuttle in colorectal cancer cells.
| العنوان: | Role of creatine shuttle in colorectal cancer cells. |
|---|---|
| المؤلفون: | Kita M; Department of Molecular Pathology, Nara Medical University, Kashihara, Nara 634-8521, Japan., Fujiwara-Tani R; Department of Molecular Pathology, Nara Medical University, Kashihara, Nara 634-8521, Japan., Kishi S; Department of Molecular Pathology, Nara Medical University, Kashihara, Nara 634-8521, Japan., Mori S; Department of Molecular Pathology, Nara Medical University, Kashihara, Nara 634-8521, Japan., Ohmori H; Department of Molecular Pathology, Nara Medical University, Kashihara, Nara 634-8521, Japan., Nakashima C; Department of Molecular Pathology, Nara Medical University, Kashihara, Nara 634-8521, Japan., Goto K; Department of Molecular Pathology, Nara Medical University, Kashihara, Nara 634-8521, Japan., Sasaki T; Department of Molecular Pathology, Nara Medical University, Kashihara, Nara 634-8521, Japan., Fujii K; Department of Molecular Pathology, Nara Medical University, Kashihara, Nara 634-8521, Japan., Kawahara I; Department of Molecular Pathology, Nara Medical University, Kashihara, Nara 634-8521, Japan., Bhawal UK; Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Chennai 600077, India., Luo Y; Jiangsu Key Laboratory of Neuroregeneration, Nantong University, Nantong, Jiangsu 226001, China., Kuniyasu H; Department of Molecular Pathology, Nara Medical University, Kashihara, Nara 634-8521, Japan. |
| المصدر: | Oncotarget [Oncotarget] 2023 May 19; Vol. 14, pp. 485-501. Date of Electronic Publication: 2023 May 19. |
| نوع المنشور: | Journal Article; Research Support, Non-U.S. Gov't |
| اللغة: | English |
| بيانات الدورية: | Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Electronic Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Albany, N.Y. : Impact Journals |
| مواضيع طبية MeSH: | Creatine*/metabolism , Colorectal Neoplasms*/genetics, Mice ; Animals ; Creatine Kinase/metabolism ; Dinitrofluorobenzene ; Creatine Kinase, Mitochondrial Form/metabolism ; Oxidative Phosphorylation ; Adenosine Triphosphate/metabolism ; ErbB Receptors/metabolism |
| مستخلص: | The creatine shuttle translocates the energy generated by oxidative phosphorylation to the cytoplasm via mitochondrial creatine kinase (MTCK) and creatine kinase B (CKB) in the cytoplasm. It is not apparent how the creatine shuttle is related to cancer. Here, we analyzed the expression and function of CKB and MTCK in colorectal cancer (CRC) and investigated the role of the creatine shuttle in CRC. Compared with normal mucosa, 184 CRC tissues had higher levels of CKB and MTCK, and these levels were associated with histological grade, tumor invasion, and distant metastasis. CK inhibitor dinitrofluorobenzene (DNFB) on CRC cell lines HT29 and CT26 inhibited cell proliferation and stemness to less than 2/3 and 1/20 of their control levels, respectively. In this treatment, the production of reactive oxygen species increased, mitochondrial respiration decreased, and mitochondrial volume and membrane potential decreased. In a syngeneic BALB/c mouse model using CT26 cells pretreated with DNFB, peritoneal metastasis was suppressed to 70%. Phosphorylation of EGFR, AKT, and ERK1/2 was inhibited in DNFB-treated tumors. High ATP concentrations prevented EGFR phosphorylation in HT29 cells following DNFB treatment, CKB or MTCK knockdown, and cyclocreatine administration. Despite not being immunoprecipitated, CKB and EGFR were brought closer together by EGF stimulation. These findings imply that blocking the creatine shuttle decreases the energy supply, suppresses oxidative phosphorylation, and blocks ATP delivery to phosphorylation signals, preventing signal transduction. These findings highlight the critical role of the creatine shuttle in cancer cells and suggest a potential new cancer treatment target. |
| References: | Int J Mol Sci. 2020 May 28;21(11):. (PMID: 32481659) Int J Oncol. 1996 May;8(5):865-73. (PMID: 21544439) Nat Methods. 2006 Dec;3(12):995-1000. (PMID: 17072308) Oncotarget. 2018 Nov 27;9(93):36561-36574. (PMID: 30564297) J Biol Chem. 1989 Feb 15;264(5):2890-7. (PMID: 2914937) Int Rev Cytol. 2000;192:223-53. (PMID: 10553281) Nat Immunol. 2022 May;23(5):692-704. (PMID: 35484407) Am J Physiol. 1986 May;250(5 Pt 1):C663-75. (PMID: 3010727) Semin Cell Dev Biol. 2020 Mar;99:40-54. (PMID: 29753879) Cell Metab. 2015 Oct 6;22(4):590-605. (PMID: 26365176) Front Pharmacol. 2021 Nov 23;12:768861. (PMID: 34887764) Br J Cancer. 2016 Jun 14;114(12):1305-12. (PMID: 27219018) Int J Cancer. 1995 Feb 8;60(4):545-53. (PMID: 7829270) Stem Cells. 2010 Jul;28(7):1132-42. (PMID: 20506541) Amino Acids. 2016 Aug;48(8):1775-84. (PMID: 27020776) Cell Metab. 2018 Dec 4;28(6):833-847.e8. (PMID: 30174304) Am J Cancer Res. 2022 Oct 15;12(10):4652-4665. (PMID: 36381321) PLoS One. 2017 Dec 29;12(12):e0190456. (PMID: 29287112) Amino Acids. 2020 Jul;52(6-7):1033-1041. (PMID: 32696177) Amino Acids. 2012 Jun;42(6):2319-30. (PMID: 21769499) J Physiol. 1975 Apr;246(3):737-52. (PMID: 1079537) Front Oncol. 2021 Jul 26;11:698951. (PMID: 34381722) Expert Opin Drug Deliv. 2012 Aug;9(8):909-35. (PMID: 22663303) Gut. 2010 Mar;59(3):348-56. (PMID: 19828468) Toxicol In Vitro. 2001 Aug-Oct;15(4-5):307-12. (PMID: 11566554) Mol Cell Biol. 1994 Dec;14(12):8483-92. (PMID: 7969181) CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30. (PMID: 26742998) Proc Natl Acad Sci U S A. 2017 Sep 12;114(37):E7697-E7706. (PMID: 28847964) Mol Cell Biochem. 2004 Jan-Feb;256-257(1-2):43-58. (PMID: 14977169) J Pathol. 2002 Feb;196(2):163-70. (PMID: 11793367) Amino Acids. 2011 May;40(5):1271-96. (PMID: 21448658) J Cancer. 2016 Jan 01;7(1):50-9. (PMID: 26722360) Drug Metab Dispos. 1992 Sep-Oct;20(5):625-31. (PMID: 1358565) Front Oncol. 2022 May 31;12:892195. (PMID: 35712500) Cancer Chemother Pharmacol. 1995;35(5):411-6. (PMID: 7850923) |
| فهرسة مساهمة: | Keywords: ATP metabolism; creatine kinase B; mitochondrial creatine kinase; phosphorylation signal; stemness |
| المشرفين على المادة: | MU72812GK0 (Creatine) EC 2.7.3.2 (Creatine Kinase) D241E059U6 (Dinitrofluorobenzene) EC 2.7.3.2 (Creatine Kinase, Mitochondrial Form) 8L70Q75FXE (Adenosine Triphosphate) EC 2.7.10.1 (ErbB Receptors) |
| تواريخ الأحداث: | Date Created: 20230519 Date Completed: 20230522 Latest Revision: 20230525 |
| رمز التحديث: | 20230526 |
| مُعرف محوري في PubMed: | PMC10197964 |
| DOI: | 10.18632/oncotarget.28436 |
| PMID: | 37204253 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 1949-2553 |
|---|---|
| DOI: | 10.18632/oncotarget.28436 |